|
You are overly dismissive of de Grey's approach, and if you're going to Wikipedia for the details of SENS then you are in the wrong place. It is documented in far more detail elsewhere. The standard response to your viewpoint is to point to the SENS Research Foundation advisory board, which includes George Church, Anthony Atala, Judith Campisi, Maria Blasco, and so on and so forth for a list of luminaries in subfields of medical research relevant to aging: http://www.sens.org/about/leadership/research-advisory-board It is also worth looking at the ongoing research collaborations, which involve noted labs at institutions such as Wake Forest, the Buck Institute, Albert Einstein College of Medicine, Cambridge University, and so on and so forth. http://www.sens.org/research/extramural I'm not sure why you think this research work is not panning out when it has barely even started. This is early stage work, creating the building blocks and foundations. The most advanced of the necessary lines of research is ablation of senescent cells, which has been shown to work in accelerated aging mice and is current in studies in normal mice. That is a few years away from technical possibility in humans, further once you add in the regulatory issues, and everything else is further into the future. |